Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $95.99M (100.0% shares, 0.0% debt)

Holdings (18)

REPL REPLIMUNE GROUP INC 12.2%

Value $11.66M Shares 1,200,000 Est. Cost — Unrealized —

ABVX ABIVAX SA 9.8%

Value $9.44M Shares 70,000 Est. Cost $134.85 Unrealized —

SLNO SOLENO THERAPEUTICS INC 8.1%

Value $7.78M Shares 168,029 Est. Cost $65.05 Unrealized -15.7%

CMPS COMPASS PATHWAYS PLC 7.9%

Value $7.59M Shares 1,100,000 Est. Cost $2.80 Unrealized —

— ATAI BECKLEY NV 7.3%

Value $7.007M Shares 1,713,105 Est. Cost $5.29 Unrealized —

IVA INVENTIVA SA 7.3%

Value $6.975M Shares 1,500,000 Est. Cost $4.65 Unrealized —

NERV MINERVA NEUROSCIENCES INC 6.9%

Value $6.655M Shares 1,655,500 Est. Cost $3.71 Unrealized 0.0%

EWTX EDGEWISE THERAPEUTICS INC 6.5%

Value $6.204M Shares 250,000 Est. Cost $20.07 Unrealized 0.0%

PRAX PRAXIS PRECISION MEDICINES I 6.1%

Value $5.86M Shares 19,882 Est. Cost $186.22 Unrealized 0.0%

EWTX EDGEWISE THERAPEUTICS INC 5.0%

Value $4.839M Shares 195,000 Est. Cost $20.07 Unrealized 0.0%

QURE UNIQURE NV 5.0%

Value $4.786M Shares 200,000 Est. Cost — Unrealized —

EPRX EUPRAXIA PHARMACEUTICALS INC 3.1%

Value $3.004M Shares 397,895 Est. Cost $5.44 Unrealized +13.3%

OVID OVID THERAPEUTICS INC 3.0%

Value $2.91M Shares 1,785,000 Est. Cost $1.54 Unrealized 0.0%

TSHA TAYSHA GENE THERAPIES INC 2.9%

Value $2.75M Shares 500,000 Est. Cost $2.83 Unrealized +71.5%

TSHA TAYSHA GENE THERAPIES INC 2.6%

Value $2.514M Shares 457,132 Est. Cost $2.83 Unrealized +71.5%

SLDB SOLID BIOSCIENCES INC 2.4%

Value $2.333M Shares 413,625 Est. Cost $3.54 Unrealized +53.3%

WHWK WHITEHAWK THERAPEUTICS INC 2.1%

Value $1.979M Shares 817,939 Est. Cost $2.27 Unrealized +1.3%

PMN PROMIS NEUROSCIENCES INC 1.8%

Value $1.702M Shares 249,339 Est. Cost $9.76 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
REPL	REPLIMUNE GROUP INC	1,200,000	$11.66M	12.2%	—	—	Call	76029N106
ABVX	ABIVAX SA	70,000	$9.44M	9.8%	$134.85	—	SPONSORED ADS	00370M103
SLNO	SOLENO THERAPEUTICS INC	168,029	$7.78M	8.1%	$65.05	-15.7%	COM	834203309
CMPS	COMPASS PATHWAYS PLC	1,100,000	$7.59M	7.9%	$2.80	—	Call	20451W101
—	ATAI BECKLEY NV	1,713,105	$7.007M	7.3%	$5.29	—	SHS	N0731H103
IVA	INVENTIVA SA	1,500,000	$6.975M	7.3%	$4.65	—	ADS	46124U107
NERV	MINERVA NEUROSCIENCES INC	1,655,500	$6.655M	6.9%	$3.71	0.0%	COM NEW	603380205
EWTX	EDGEWISE THERAPEUTICS INC	250,000	$6.204M	6.5%	$20.07	0.0%	Put	28036F105
PRAX	PRAXIS PRECISION MEDICINES I	19,882	$5.86M	6.1%	$186.22	0.0%	COM NEW	74006W207
EWTX	EDGEWISE THERAPEUTICS INC	195,000	$4.839M	5.0%	$20.07	0.0%	COM	28036F105
QURE	UNIQURE NV	200,000	$4.786M	5.0%	—	—	Call	N90064101
EPRX	EUPRAXIA PHARMACEUTICALS INC	397,895	$3.004M	3.1%	$5.44	+13.3%	COM	29842P105
OVID	OVID THERAPEUTICS INC	1,785,000	$2.91M	3.0%	$1.54	0.0%	COM	690469101
TSHA	TAYSHA GENE THERAPIES INC	500,000	$2.75M	2.9%	$2.83	+71.5%	Call	877619106
TSHA	TAYSHA GENE THERAPIES INC	457,132	$2.514M	2.6%	$2.83	+71.5%	COM SHS	877619106
SLDB	SOLID BIOSCIENCES INC	413,625	$2.333M	2.4%	$3.54	+53.3%	COM NEW	83422E204
WHWK	WHITEHAWK THERAPEUTICS INC	817,939	$1.979M	2.1%	$2.27	+1.3%	COM	00032Q104
PMN	PROMIS NEUROSCIENCES INC	249,339	$1.702M	1.8%	$9.76	0.0%	COM SHS	74346M505